Novartis Home
At Novartis, we are reimagining medicine
Novartis Lecture with Bertrand Bodson
Why healthcare's digital moment is now
Bertrand Bodson, Novartis CDO hosted a fireside chat with Microsft Exec Peter Lee to explore their health moonshots, COVID response and more.
Novartis at ASH
Find the latest resources about Novartis data featured at the American Society of Hematology (ASH) Annual Meeting & Exposition.
Join the Co-Creating Impact Summit 2020
Novartis is hosting the Co-Creating Impact Summit on December 9th, 2020, gathering experts inside and outside of the company to discuss some key ESG topics.
Novartis included in Dow Jones Sustainability Index
Novartis is proud to be included in one of the most important ESG ratings.
Going 100% renewable in Europe
Novartis signs agreements expected to add more than 275 megawatts of clean power to the electrical grid.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
1_4y4ere9u
Our people, our stories, our culture on @novartislife Instagram
Find out more about our Inspired, Curious and Unbossed culture as we celebrate our people who are reimagining medicine and their stories on our new community channel @novartislife.
Cell & Gene Therapy Explained
What if medicine for certain diseases only needed to be taken once?
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Our commitment to doing what's right
Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.